tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Royalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra
PremiumThe FlyRoyalty Pharma confirms acquisition of royalty interest in Amgen’s Imdelltra
29d ago
BeOne Medicines to sell royalty rights of Imdelltra to Royalty Pharma for $950M
Premium
The Fly
BeOne Medicines to sell royalty rights of Imdelltra to Royalty Pharma for $950M
29d ago
BeOne Medicines’ Brukinsa tablet formulation approved by European Commission
Premium
The Fly
BeOne Medicines’ Brukinsa tablet formulation approved by European Commission
1M ago
BeOne Medicines Reports Strong Q2 2025 Performance
PremiumCompany AnnouncementsBeOne Medicines Reports Strong Q2 2025 Performance
2M ago
BeiGene’s Earnings Call Highlights Robust Growth and Market Leadership
Premium
Company Announcements
BeiGene’s Earnings Call Highlights Robust Growth and Market Leadership
2M ago
BeOne Medicines: Strong Financial Performance and Promising Pipeline Justify Buy Rating and Increased Price Target
Premium
Ratings
BeOne Medicines: Strong Financial Performance and Promising Pipeline Justify Buy Rating and Increased Price Target
2M ago
BeOne Medicines price target raised to $345 from $321 at JPMorgan
PremiumThe FlyBeOne Medicines price target raised to $345 from $321 at JPMorgan
2M ago
BeOne Medicines price target raised to $349 from $311 at RBC Capital
Premium
The Fly
BeOne Medicines price target raised to $349 from $311 at RBC Capital
2M ago
BeOne announces EC approval of Tevimbra in combination with chemotherapy
Premium
The Fly
BeOne announces EC approval of Tevimbra in combination with chemotherapy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100